Litcius/Paper detail

Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial

Trong Toan Nguyen, Cheng-Hsun Chiu, Chien-Yu Lin, Nan-Chang Chiu, Po-Yen Chen, Thi Tuong Vy Le, Dang Ngan Le, An Han Duong, Van Luan Nguyen, Thi Nguyet Huynh, Huu Khanh Truong, Trong Lan Phan, Thi Thanh Thao Nguyen, Shin-Ru Shih, Chung‑Guei Huang, Yi-Jen Weng, Erh-Fang Hsieh, Stanley Chang, Charles Chen, I-Chen Tai, Li-Min Huang

2022The Lancet61 citationsDOI

Topics & Concepts

ImmunogenicityMedicineVirologyChristian ministryEnterovirus 71ImmunologyEnterovirusAntibody responseAntibodyPhase (matter)Clinical trialVaccinationImmunizationViral Infections and Immunology ResearchViral gastroenteritis research and epidemiologyRespiratory viral infections research
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial | Litcius